Searched for
RUBICON RESEARCH FINANCIALS
HDFC Mutual Fund: RIL and Paytm among stocks bought and sold in OctoberHDFC Mutual Fund made significant portfolio adjustments in October. The fund house boosted its stake in nearly 201 companies, featuring RIL...
Rubicon Research shares can rally 22%, says Motilal Oswal after initiating with ‘Buy’ ratingShares of Rubicon Research rose up to 3% on October 31 after Motilal Oswal initiated coverage with a ‘Buy’ rating and a target price of Rs ...
Healthy start! Rubicon Research shares list at 28% premium over IPO priceRubicon Research Share Price debuted on stock exchanges with a significant 27.9% premium, opening at Rs 620. The Rs 1,377 crore IPO saw ove...
Rubicon Research IPO allotment date today: GMP at Rs 95; How to check status on BSE and MUFG IntimeRubicon Research IPO Allotment Status: Rubicon Research's Rs 1,377 crore IPO concluded with strong investor demand, oversubscribing 109.35 ...
Canara Robeco AMC IPO Day 3: Issue fully subscribed on strong NII push; GMP fallsCanara Robeco AMC's Rs 1,326 crore IPO was fully subscribed on its final day, driven by strong interest from non-institutional investors. D...
Rubicon Research IPO Day 3: GMP, subscription status, brokerage views, and key highlightsRubicon Research’s IPO, backed by Arihant Capital with a “Subscribe” rating, highlights the company’s strong growth and diversified pharma ...
Rubicon Research IPO Day 2: Issue booked 2.37 times. Check GMP, other detailsRubicon Research's IPO saw strong investor demand, subscribed 2.37 times. The pharma firm specializes in generics and specialty drugs. Its ...
Rubicon Research IPO Day 1: Subscribed 51% in initial hours – Check GMP, Brokerages' views, and key detailsRubicon Research IPO: Rubicon Research is trading at a grey market premium of ₹90, roughly 19% above the upper price band, reflecting stron...
Rubicon Research IPO: Check GMP, brokerages review, subscription and other detailsRubicon Research's Rs 1,377 crore IPO opens on October 9. The specialty and generics pharmaceutical manufacturer offers shares at Rs 461-48...
Can Rubicon Research sustain its impressive growth while facing US market risks?Rubicon Research plans to raise ₹500 crore through a fresh issue for debt repayment and acquisitions, alongside an ₹877.5 crore offer for s...
Tata Capital, LG Electronics India to launch IPOs worth over Rs 27,000 crore next weekThe primary market is set for a busy week as two major companies, Tata Capital Ltd and LG Electronics India Ltd, gear up to launch their in...
IPO Calendar: LG, Tata Capital among issues worth Rs 28,500 crore to hit the Street next weekIndia's primary market prepares for a week of public issues. Five IPOs worth over Rs 28,500 crore will launch. Tata Capital and LG Electron...
Ireland may be the place you've been looking for to start your new businessDublin has a strong investor community and is already home to over 2200 startups. The city has a highly educated workforce and when combine...
Looking for R&D opportunities? How Ireland could be a good option for youIreland has emerged as one of the leading global centres for Research, Development, and Innovation. The country offers an ideal commercial,...
Anthem Bio catches global buyout funds' eye, stake sale could see valuation rocket to $1 billionLaunched by ex-Biocon executive Ajay Bharadwaj, the Rs 1,200 crore Anthem Biosciences competes with Syngene International and GVK Bio. O3 C...
Urjit Patel quit as government undermined RBI’s autonomy, says Viral Acharya in his new bookAcharya’s book is a compendium of his speeches, research and comments as member of the Monetary Policy Committee — mostly concerned with ce...
Everstone looks to sell Singapore IT firm Everise, pegs stake at $300 mEverstone, which manages assets in excess of $5 billion, had partnered with Sunrise BPO in 2016 to launch Everise and expanded the business...
Blackstone, KKR, Bain among PE cos in talks to buy Granules IndiaThe investor relations team at Granules India denied the promoters are seeking to sell their stake.
General Atlantic to acquire Rubicon as Everstone Cap exitsThe acquisition would mark General Atlantic’s renewed focus on pharma, the buyout major having also backed Jubilant Lifesciences.
Bill Gates: The real revolution will be self-driving cars, and Uber could get there firstFT Alphaville writer Izabella Kaminska, who often writes about these issues, went on a long tweetstorm after relaying the conversation.